| Open Document File Size: 526,79 KBShare Result on Facebook
City Houston / Sverdlovsk / London / Vineyard / / Company Mary Ann Liebert Inc. / / Continent North America / / Country United States / Soviet Union / United Kingdom / Sweden / Spain / / Event Product Issues / / IndustryTerm local healthcare facilities / statistical tool / literature search / healthcare facilities / / MedicalCondition pulmonary involvement / untreated tularemia / pneumonia / Two epidemic modeling studies / Inhalational Tularemia / disease / notable inhalational tularemia outbreaks / Parameters Parameter Description Value rf Infectious / untreated disease / human infection / human/primate infection / clinical illness / MODELING INHALATIONAL TULAREMIA / published tularemia experiments / tularemia / MODELING INHALATIONAL TULAREMIA II / tularemia outbreak / pulmonary complications / clinically overt disease / large tularemia outbreak / tularemia therapy / inhalational tularemia cases / infection / subsequent disease / anthrax / infectious animal tissues / illness / tularemia cases / best fit infectious dose-response / handling infectious animal tissues / / MedicalTreatment antibiotics / antibiotic therapy / / Organization Emergency Response Department / Salisbury / U.S. Defense Threat Reduction Agency / Health Protection Agency / / Person EGAN ET AL / Joseph R. Egan / Ian M. Hall / Steve Leach / / Position Scientific Programme Leader / Scientific Programme Head / rt / Controller / / Product Mass Antibiotic / doxycycline / ciprofloxacin / C 300 / hay / environments / / ProvinceOrState Texas / Massachusetts / / Region southeast England / / Technology aero / / URL www.liebertonline.com/bsp / /
SocialTag |
Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science Volume 9, Number 4, 2011 ª Mary Ann Liebert, Inc. DOI: [removed]bsp[removed]Modeling Inhalational Tularemia: Deliberate Release and Public Health